Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
- Dyslipidemia
Cardiovascular diseases (CVDs) are the leading cause of death globally1
According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.
A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.
- Dyslipidemia
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)
- Thrombosis
Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade
Danish study finds more elderly and patients with comorbidities being diagnosed.
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
- Dyslipidemia
Cardiovascular diseases (CVDs) are the leading cause of death globally1
According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.
A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.
- Dyslipidemia
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)
- Thrombosis
Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade
Danish study finds more elderly and patients with comorbidities being diagnosed.
Events
Stay up to date and register for the latest events and view webinar recordings.
Advancing the Standard of Care: Addressing Progression in MS
An evidence-based exploration of the current MS landscape, focusing on the pathophysiology of Progression Independent of Relapse Activity (PIRA). This module examines the clinical significance of disability accumulation and the remaining unmet needs in long-term patient management.
Safe & Smart: Cardio Safe & Gluco Smart Approach in Diabetes Management
This engagement will address the unmet medical needs in diabetes quinary management through Multidisciplinary Team of top experts in the field of endocrinology and internal medicine in Gulf, India, Levant and Egypt.
- Neurological Disorders
Sir Robin Murray updates us on Schizophrenia and it’s treatments
Updates on the Causes and Treatments of Schizophrenia
World Diabetes Day
Dr. Hussein Elbadawi talks about Hypoglycemia and how is it classified.
Safe & Smart - Dr. Salah
Dr. Salah gives us the updated guidelines on Sulphonylureas and Cardiovascular safety
leave-site-modal-text
You will now be leaving the site
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.